Current Molecular Pharmacology


Michael Kahn
(16435 citations)
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 2, June 2012

EDITORIAL [Hot Topic-I: Molecular and Pharmacological Aspects of Existing and Experimental Bone Anabolic Therapies (Guest Editor: Naibedya Chattopadhyay)]

Volume:5   Issue: 2
Pp: 125-126
Naibedya Chattopadhyay
DOI: 10.2174/1874467211205020125
Published on: 21 May, 2012

Anabolic Effects of Intermittent PTH on Osteoblasts

Volume:5   Issue: 2
Pp: 127-134
Edward M. Greenfield
DOI: 10.2174/1874467211205020127
Published on: 21 May, 2012

Insulin Like Growth Factor-I: A Critical Mediator of the Skeletal Response to Parathyroid Hormone

Volume:5   Issue: 2
Pp: 135-142
Daniel D. Bikle and Yongmei Wang
DOI: 10.2174/1874467211205020135
Published on: 21 May, 2012

The Role of BMPs in Bone Anabolism and their Potential Targets SOST and DKK1

Volume:5   Issue: 2
Pp: 153-163
Nobuhiro Kamiya
DOI: 10.2174/1874467211205020153
Published on: 21 May, 2012

Potential of Modulating Wnt Signaling Pathway Toward the Development of Bone Anabolic Agent

Volume:5   Issue: 2
Pp: 164-173
Ulf Krause and Carl A. Gregory
DOI: 10.2174/1874467211205020164
Published on: 21 May, 2012

Prostaglandin E2 Receptors as Potential Bone Anabolic Targets – Selective EP4 Receptor Agonists

Volume:5   Issue: 2
Pp: 174-181
Joseph Pagkalos, Andreas Leonidou, Mohammed As-Sultany, Manolis Heliotis, Athanasios Mantalaris and Eleftherios Tsiridis
DOI: 10.2174/1874467211205020174
Published on: 21 May, 2012

Antagonizing the Calcium-Sensing Receptor: Towards New Bone Anabolics?

Volume:5   Issue: 2
Pp: 182-188
Daniela Riccardi
DOI: 10.2174/1874467211205020182
Published on: 21 May, 2012

Potential Anti-Catabolic and Anabolic Properties of Strontium Ranelate

Volume:5   Issue: 2
Pp: 189-194
Romuald Mentaverri, Michel Brazier, Said Kamel and Patrice Fardellone
DOI: 10.2174/1874467211205020189
Published on: 21 May, 2012

Activin Receptor Signaling: A Potential Therapeutic Target for Osteoporosis

Volume:5   Issue: 2
Pp: 195-204
Sutada Lotinun, R. Scott Pearsall, William C. Horne and Roland Baron
DOI: 10.2174/1874467211205020195
Published on: 21 May, 2012

Naturally Plant-Derived Compounds: Role in Bone Anabolism

Volume:5   Issue: 2
Pp: 205-218
Marie-Noelle Horcajada and Elizabeth Offord
DOI: 10.2174/1874467211205020205
Published on: 21 May, 2012

EDITORIAL [Hot Topic-II: PPAR Ligands and Cardiovascular Disorders: Friend or Foe (Guest Editors: Pitchai Balakumar and Gowraganahalli Jagadeesh)]

Volume:5   Issue: 2
Pp: 219-223
Pitchai Balakumar and Gowraganahalli Jagadeesh
DOI: 10.2174/1874467211205020219
Published on: 21 May, 2012

The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress

Volume:5   Issue: 2
Pp: 224-240
M. C. Sugden, M. P. Warlow and M. J. Holness
DOI: 10.2174/1874467211205020224
Published on: 21 May, 2012

Healing the Diabetic Heart: Modulation of Cardiometabolic Syndrome through Peroxisome Proliferator Activated Receptors (PPARs)

Volume:5   Issue: 2
Pp: 241-247
Tom Hsun-Wei Huang and Basil D. Roufogalis
DOI: 10.2174/1874467211205020241
Published on: 21 May, 2012

Effects of PPARγ Agonists against Vascular and Renal Dysfunction

Volume:5   Issue: 2
Pp: 248-254
Akira Sugawara, Akira Uruno, Ken Matsuda, Takako Saito-Ito, Tadao Funato, Akiko Saito-Hakoda, Masataka Kudo and Sadayoshi Ito
DOI: 10.2174/1874467211205020248
Published on: 21 May, 2012

Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

Volume:5   Issue: 2
Pp: 272-281
Giuseppe Derosa and Pamela Maffioli
DOI: 10.2174/1874467211205020272
Published on: 21 May, 2012

Effects of PPARγ Ligands on Vascular Tone

Volume:5   Issue: 2
Pp: 282-291
Salvatore Salomone and Filippo Drago
DOI: 10.2174/1874467211205020282
Published on: 21 May, 2012

PPAR-γ Agonists in Polycystic Kidney Disease with Frequent Development of Cardiovascular Disorders

Volume:5   Issue: 2
Pp: 292-300
Shizuko Nagao and Tamio Yamaguchi
DOI: 10.2174/1874467211205020292
Published on: 21 May, 2012

The Application of Mass Spectrometry to Proteomics and Metabolomics in Biomarker Discovery and Drug Development

Volume:5   Issue: 2
Pp: 301-316
Toshiyuki Mikami, Mikio Aoki and Toru Kimura
DOI: 10.2174/1874467211205020301
Published on: 21 May, 2012